UNSPSC 51113502: Piposulfan

This classification denotes an alkylsulfonate compound with the molecular formula C12H22N2O8S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VY5DPN1TDU, chemically known as 1,4-dihydracryloylpiperazine dimethanesulfonate (ester) but more generally known as piposulfan, which bears US NIH Compound Identifier 17458. European Medicines Agency schedules Piposulfan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09878MIG. The term PIPOSULFAN is an International Non-Proprietary Name.

UNSPSC 51113502 Piposulfan is a Commodity code covering procurement of this specialized chemotherapy agent by state and local health systems, correctional facilities, and public hospitals. The code spans the purchase of piposulfan, a nitrogen mustard alkylating agent used in cancer treatment protocols, typically sourced through pharmaceutical wholesalers, group purchasing organizations, or direct manufacturer contracts. State and local buying entities include state departments of health, county health departments, public hospital systems, and state correctional health services that maintain oncology or chemotherapy programs. The product is procured as a single-unit or bulk pharmaceutical supply, often bundled with broader chemotherapy or cancer-treatment procurement vehicles rather than as a standalone solicitation.

The source contains no recent state and local contract opportunities tagged to this code. Without posted RFP, RFQ, IFB, or ITB records in the available data, no issuing bodies, geographic concentrations, or response dates can be identified. Piposulfan procurement at the state and local level typically occurs through standing group purchasing agreements, state pharmaceutical contracts, or health system formulary management rather than through visible competitive solicitations, making activity under this code difficult to track through public notice channels.